Veru Inc.

Healthcare

NASDAQ:VERU · NASDAQ Capital Market

Market Cap $50.24M Beta -1.13 P/E (TTM) -4.8

$3.13 +4.33%

+$0.13 today

52W Low $2.05High $7.33

Vol 0.69M · Avg 1.82M

EPS (TTM) -$0.65Biotechnology

Filings

Ground the analysis in primary documents

Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.

Price History

Dividend-adjusted closing price

Events

Change

-49.52%

Period High

$6.95

Period Low

$2.09

Latest

$3.13

SEC Filings

Recent regulatory filings

No filings found.

Competitors

Peer companies in the same sector

Health

MAIA Biotechnology, Inc.

AMEX:MAIA

$82.69M

PolyPid Ltd.

PYPD

$47.54M

BioXcel Therapeutics, Inc.

BTAI

$35.82M

Mural Oncology plc

MURA

$35.38M

Annovis Bio, Inc.

ANVS

$35.02M

RenovoRx, Inc.

RNXT

$32.97M

Dyadic International, Inc.

DYAI

$29.00M

Celularity Inc.

CELU

$18.52M

BioAtla, Inc.

BCAB

$4.56M

Reviva Pharmaceuticals Holdings, Inc.

RVPH

$2.35M

What is the latest VERU filing?

The latest filing shown is 8-K dated Jun 4, 2026.

How many recent filings does VERU have?

Intrinsic Alpha currently shows 20 recent filings for VERU.

Explore More

Continue the stock analysis

Jump to another research area for this company.

OverviewStart with valuation, alerts, peers, and the full company snapshot.DCFAdjust assumptions and compare intrinsic value against the market price.FinancialsReview income statement, balance sheet, and cash flow trends.HealthCheck liquidity, leverage, and balance sheet strength.GrowthCompare historical growth, cash generation, targets, and peers.DividendsInspect dividend history, payout durability, and shareholder returns.ManagementReview leadership context, insider activity, and capital efficiency.